Skip to content
OpenCapital
Get started

Tempest Therapeutics TPST Q1 2026 earnings

Reported May 15, 2026 · Before market open

EPS-$0.51Miss by $0.23
EPS estimate-$0.28

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.30

Versus estimates

Diluted EPS

Q1 2026-$0.51Miss by $0.23
Q4 2025-$0.62In lineQ3 2025-$0.79Beat by $2.48Q2 2025-$2.07Beat by $1.16Q1 2025-$3.16Beat by $0.55Q4 2024-$4.03Miss by $0.91

Ask the moment Tempest Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Tempest Therapeutics report Q1 2026 earnings?
Tempest Therapeutics (TPST) reported Q1 2026 earnings on May 15, 2026 before market open.
What were Tempest Therapeutics's Q1 2026 revenue and EPS?
Tempest Therapeutics reported eps of $-0.51 for Q1 2026.
Did Tempest Therapeutics beat estimates in Q1 2026?
EPS missed the consensus estimate of $-0.28 by $0.23.
How did Tempest Therapeutics's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 83.9% from $-3.16.
Where can I find Tempest Therapeutics's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-224156) and the 10-Q periodic report (0001193125-26-224289) directly on SEC EDGAR. The filing index links above go to sec.gov.